Other languages Catalyst Pharmaceuticals, Inc.

Equities

CPRX

US14888U1016

Delayed Nasdaq Other stock markets 01:29:07 22/06/2024 am IST			5-day change	1st Jan Change
15.56 ^USD	+2.50%		+2.92%	-7.79%

05/06	Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing	MT
30/05	Sector Update: Health Care Stocks Mixed Late Afternoon	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing	06/06
Sector Update: Health Care Stocks Mixed Late Afternoon	31/05
Catalyst Pharmaceuticals Gets FDA Approval for Dose Increase in LEMS Drug	30/05
Catalyst Pharmaceuticals, Inc. Reaffirms Revenue Guidance for the Full-Year 2024	09/05
Catalyst Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Santhera dans les chiffres noirs en 2023	25/04
Catalyst Pharmaceuticals Insider Sold Shares Worth $392,000, According to a Recent SEC Filing	11/04
Catalyst Pharmaceuticals Insider Sold Shares Worth $411,000, According to a Recent SEC Filing	29/03
Santhera-Partner Catalyst Pharmaceuticals lanciert Agamree in den USA	14/03
Santhera: lancement de l'Agamree contre la myopathie de Duchenne aux USA	14/03
Catalyst Pharmaceuticals' Agamree Now Available in US to Treat Duchenne Muscular Dystrophy	13/03
Catalyst Pharmaceuticals Announces Agamree® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy	13/03
Catalyst Pharmaceuticals Receives Buy Rating From BofA on Track Record for License, Acquisition Deals	07/03
Catalyst Pharmaceuticals, Inc. Provides Revenue Guidance for the Year 2024	29/02
Catalyst Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Catalyst Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Catalyst Pharmaceuticals Seeks Acquisitions	10/01
Catalyst Pharmaceuticals Raises $140.1 Million From Share Offering	10/01
Top Stories at Midday: December US Nonfarm Payrolls Rise; ISM US Services Index Falls; CVS Names Finance Chief; Tesla to Recall Vehicles in China; Catalyst Prices Stock Offering	05/01
Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday	05/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Catalyst Pharmaceuticals, Inc: Optimistic scenario

March 06, 2023 at 09:14 pm IST